Kategorien
Aktien

Xeris Pharmaceuticals Inc 3,48 USD -0,28% 

SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
ISIN US98422L1070
USD
  • Xeris Pharmaceuticals Inc
    Börse Börse Berlin
    EUR
  • Xeris Pharmaceuticals Inc
    Börse Börse Frankfurt
    EUR
  • Xeris Pharmaceuticals Inc
    Börse Börse München
    EUR
  • ISIN US98422L1070 WKN: A2JPE9
    Symbol XERS
    USD
  • Xeris Pharmaceuticals, Inc.
    Börse London Stock Exchange
ISIN US98422L1070
WKN A2JPE9
Symbol XERS
Währung USD
Marktkapitalisierung 237.276.448 (+- 20%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

284.552.896 oder 190.000.000

Mitarbeiter 213 (+- 19%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

172 oder 253 Mitarbeiter

EBITDA -94.216.000
PEGRatio None
Buchwert 0.307

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 3,48 USD -0,28% 

30 News & Informationen zur Xeris Pharmaceuticals Inc Aktie

  • Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)
    marketscreener.com

    Strongbridge Biopharma : Certain Litigation Relating to the Transaction (Form 8-K)

    Certain Litigation Relating to the Transaction

    As previously disclosed, on May 24, 2021, Strongbridge Biopharma plc entered into a Transaction Agreement with Xeris… | August 30, 2021

  • 60 Biggest Movers From Yesterday
    markets.businessinsider.com

    60 Biggest Movers From Yesterday

    Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf…

  • Xeris Pharmaceuticals Shares Rise 18% on FDA Approval for sNDA
    marketscreener.com

    Xeris Pharmaceuticals Shares Rise 18% on FDA Approval for sNDA

    By Chris Wack

    Xeris Pharmaceuticals Inc. shares were up 18% to $2.60 after the company said the supplemental new drug application for its Gvoke Kit was approved by the U.S. Food and Drug… | August 23, 2021

  • Trending Penny Stocks To Buy For Under $3 Right Now
    pennystocks.com

  • Xeris Pharmaceuticals Strengthens Its Patent Estate
    thestreet.com

    Xeris Pharmaceuticals Strengthens Its Patent Estate

    Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize

  • INVESTIGATION: Halper Sadeh LLP Investigates SBBP, QTS, GRA, SWN, ONEM, IKNX; Shareholders are Encouraged to Contact the Firm
    marketscreener.com

    INVESTIGATION: Halper Sadeh LLP Investigates SBBP, QTS, GRA, SWN, ONEM, IKNX; Shareholders are Encouraged to Contact the Firm

    NEW YORK, Aug. 16, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

    … | August 16, 2021

  • Xeris Pharmaceuticals Achieves Unprecedented Levels Of Payor Coverage For Gvoke®
    thestreet.com

    Xeris Pharmaceuticals Achieves Unprecedented Levels Of Payor Coverage For Gvoke®

    Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize

  • Futures Hit Fresh Record High Ahead Of PPI, Claims Data
    zerohedge.com

    Futures Hit Fresh Record High Ahead Of PPI, Claims Data

    ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero

  • Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL……
    markets.businessinsider.com

    Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL……

    (RTTNews) – Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL…… The following are some of the stocks making big moves in Thursday's pre-market trad…

  • Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL……
    rttnews.com

    Pre-market Movers: CNFR, XONE, XERS, OPEN, MDVL……

    The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.26 A.M. EDT)..

  • Stocks That Hit 52-Week Lows On Thursday
    benzinga.com

    Stocks That Hit 52-Week Lows On Thursday

    During Thursday's morning session, 77 companies made new 52-week lows.
    Areas of Interest: The largest company in terms of market cap to …

  • Earnings Scheduled For August 5, 2021
    benzinga.com

    Earnings Scheduled For August 5, 2021

    Companies Reporting Before The Bell
    • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …

  • EDGAR Filing Documents for 0001193125-21-230205
    sec.gov

  • Xeris Pharmaceuticals : Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
    marketscreener.com

    Xeris Pharmaceuticals : Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

    Xeris Pharmaceuticals, Inc. today announced in accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013 that, as of the close of business on July 28, 2021, Xeris'… | July 29, 2021

  • Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
    finanzen.net

    Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

    Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue | Nachricht | finanzen.net

  • Were Hedge Funds Right About Eiger BioPharmaceuticals, Inc. (EIGR)?
    insidermonkey.com

    Were Hedge Funds Right About Eiger BioPharmaceuticals, Inc. (EIGR)?

    How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…

  • Xeris Pharmaceuticals To Announce Second Quarter 2021 Financial Results And Host Conference Call And Webcast On August 5, 2021
    thestreet.com

    Xeris Pharmaceuticals To Announce Second Quarter 2021 Financial Results And Host Conference Call And Webcast On August 5, 2021

    Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and

  • Powell Investment Advisors, LLC Buys Ford Motor Co, ARK Innovation ETF, CVS Health Corp, Sells Nuveen AMT-Free Municipal Credit Income...
    gurufocus.com

    Powell Investment Advisors, LLC Buys Ford Motor Co, ARK Innovation ETF, CVS Health Corp, Sells Nuveen AMT-Free Municipal Credit Income Fund, Alerian MLP ETF, AMMO Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Invesco ltd: Form 8.3 - Xeris Pharmaceuticals Plc.
    globenewswire.com

    Invesco ltd: Form 8.3 – Xeris Pharmaceuticals Plc.

    price                         Form 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 …

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations
    marketscreener.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations

    NEW YORK, July 7, 2021 /PRNewswire/ —

    If you own shares in any of the companies… | July 7, 2021

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations
    thestreet.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations

    NEW YORK, July 7, 2021 /PRNewswire/ —

    If you own shares in any of the companies listed above and would like to discuss our investigations or have

  • Invesco ltd: Form 8.3 - Xeris Pharmaceuticals Plc.
    globenewswire.com

    Invesco ltd: Form 8.3 – Xeris Pharmaceuticals Plc.

    Form 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS…

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RIVE, ESXB, ICON, SBBP; Shareholders are Encouraged to Contact the Firm
    marketscreener.com

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RIVE, ESXB, ICON, SBBP; Shareholders are Encouraged to Contact the Firm

    NEW YORK, July 3, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

    … | July 4, 2021

  • Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    thestreet.com

    Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations
    markets.businessinsider.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations

    NEW YORK, June 29, 2021 /PRNewswire/ –If you own shares in any of the companies listed above and would like to discuss our investigations or have…

  • Best Penny Stocks to Buy Right Now? 15 To Watch In July
    pennystocks.com

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm
    marketscreener.com

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm

    NEW YORK, June 24, 2021 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

    … | June 24, 2021

  • INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm
    prnewswire.com

    INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm

    /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Nicolet Bankshares, Inc. (NASDAQ:…

  • Invesco ltd: Form 8.3 - Xeris Pharmaceuticals, Inc.
    globenewswire.com

    Invesco ltd: Form 8.3 – Xeris Pharmaceuticals, Inc.

    Form 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS…

  • 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 243%
    pennystocks.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Ein ETF investiert in Xeris Pharmaceuticals, Inc

Dir gefallen die Informationen zu Xeris Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Xeris Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Xeris Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Xeris Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect